A detailed history of Man Group PLC transactions in Viatris Inc stock. As of the latest transaction made, Man Group PLC holds 24,685 shares of VTRS stock, worth $311,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,685
Holding current value
$311,524
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $254,749 - $299,429
24,685 New
24,685 $286,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $3.64 Million - $4.37 Million
322,692 New
322,692 $3.85 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $1.43 Million - $1.91 Million
-155,574 Reduced 86.66%
23,955 $230,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $428,718 - $568,347
-49,165 Reduced 21.5%
179,529 $2 Million
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $265,339 - $348,257
-31,290 Reduced 12.04%
228,694 $1.95 Million
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $310,161 - $382,480
-31,172 Reduced 10.71%
259,984 $2.72 Million
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $2.35 Million - $3.69 Million
239,707 Added 465.91%
291,156 $3.17 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $194,794 - $236,524
16,112 Added 45.6%
51,449 $695,000
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $198 - $226
-15 Reduced 0.04%
35,337 $479,000
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $200,749 - $249,969
-15,478 Reduced 30.45%
35,352 $506,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $469,425 - $640,408
-34,542 Reduced 40.46%
50,830 $710,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $1.22 Million - $1.6 Million
85,372 New
85,372 $1.6 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.3B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.